maybe our hearts needed to be broken, so they could expand .. re Shane Clancy murder ..FIDDAMAN

Our hearts are broken, but maybe our hearts needed to be broken, so they could expand’


http://www.irishexaminer.com/world/snsneyauql/rss2/

Tuesday, August 25, 2009



MOURNERS at the funeral Mass for Bray student Sebastian Creane were asked to give thought to the 22-year-old art and design student’s broken-hearted girlfriend, Jennifer Hannigan, who blamed herself for the boy’s death.



"Our hearts are broken, but maybe our hearts needed to be broken, so that they could expand," said Nuala Creane in a tribute to her dead son which was given a standing ovation.



"Please, bring to mind a happy moment in your lives. The happier the better.



"Now, let that happy feeling fill your whole body. Now bring your attention to Jen. She feels so responsible. She blames herself. Make her heart feel that happiness.



"Keep sending her your happiness. And then forgive yourselves."



Ms Hannigan suffered serious injuries when her ex-boyfriend ShaneClancy, believed to be jealous over her relatively new relationship with Sebastian, launched a brutal attack before turning a knife on himself.



The vicious assault was carried out at Mr Creane’s house in the Cuala Grove area of Bray in the early hours of Sunday, August 16.



Nuala Creane said her son was the light while Shane Clancy, who knifed himself in the heart after the frenzied attack, was the darkness.



"I notice that both boys who died were 22, both had the same initials, both were about to enter their final year in college and looked set, even in these recessionary times, to have fruitful careers," she said.



"So many similarities. Yet on the morning of August 16 my God of small things said to me, one boy represented the light, the other the darkness."



Among the mourners at the Church of the Most Holy Redeemer in Bray was Sebastian’sfather, James, as well as his brother, Dylan, who was also injured in the attack.



A white piano rested at the side of the altar – close family friend Phil Coulter, who offered his own public tribute to Sebastian last week, played throughout the service.



Bridge Over Troubled Water and Steal Away were performed by the Derry-born composer, accompanied by singer Tommy Fleming.



Friends and relatives offered Prayers of the Faithful, with tributes to Sebastian’s patience and his talents for photography, music and skateboarding.

Among the hundreds of mourners who packed the side aisles of the Bray chapelto pay their final respects was Europe Minister Dick Roche.



After the service Sebastian’s remains were taken to St Muredach’s Cathedral in Ballina, Co Mayo, for prayers followed by burial in nearby Leigue Cemetery.

Amy Winehouse - Back to Black - Dingle Ireland 2006

http://www.guardian.co.uk/music/2012/jul/22/amy-winehouse-first-anniversary-death?newsfeed=true

Fiddaman used self hypnosis .... he regressed to childhood, but did he find his way back?

"Is it possible to regress oneself? If so, how do you find your way back? ......"










https://groups.google.com/forum/?fromgroups#!topic/alt.hypnosis/4cY9u0-19T0

Regulator bans psychiatric drug Halcion ...MHRA has courage, unlike FIDDAMAN who has no phone in on radio show !

A GOVERNMENT ban on Halcion, the world's top-selling sleeping drug, has been extended for three months until October.


The decision follows an appeal by the Upjohn Company, which makes the drug, before the UK Medicines Commission in May. A rapid decision on the drug's fate had been expected.

http://www.independent.co.uk/news/uk/uk-extends-its-ban-on-halcion-sleep-drug-1532306.html

However, Upjohn received a letter informing it of the continued suspension of the drug's licence (effective from 2 July) only last week. A final decision would be made in the near future, according to the letter, signed by Dr Keith Jones, head of the Medicines Control Agency.



The agency is thought to be reserving its final decision until the European Committee for Proprietary Medicinal Products reports on its review of short-acting sleeping drugs and sedatives, such as Halcion, according to Scrip, the pharmaceutical industry newsletter. Alternatively, the UK authorities may be re-assessing all the clinical data on the drug. The Department of Health declined to comment on the MCA decision.



Halcion has been linked with amnesia, paranoia, aggression and other psychiatric disturbances. Hundreds of people here and in the United States are seeking damages because of claimed side- effects.



Halcion was withdrawn in October 1991 after data from a clinical trial was resubmitted to the Committee on Safety of Medicines, the Government's drug safety watchdog. The data had been missing from a summary presented to the CSM as part of Upjohn's original UK licence application.



An appeal to the CSM in December 1991 was rejected. In May the American Food and Drug Administration decided Halcion could continue to be prescribed but recommended that warning labels be strengthened

BBC PANORAMA libeled psychiatric drug maker UPJOHN ..no news there then, FIDDAMAN?

THE BBC is facing a pounds 1.5m bill after losing one of the longest and most costly libel cases in British history. The multi-party action over the sleeping pill Halcion took 65 days and is estimated to have generated total costs of pounds 4m. Last week one of the law chambers involved had to call in removal men to clear part of the paperwork.


The case involved the American drug company Upjohn; the BBC Panorama programme and its reporter Tom Mangold; Professor Ian Oswald, a retired Edinburgh psychiatrist, and Dr Royston Drucker, an Upjohn physician.



http://www.independent.co.uk/news/uk/bbc-faces-pounds-15m-bill-after-libel-case-drug-company-wins-damages-over-claims-in-tv-programme-celia-hall-reports-1439019.html



Halcion, once the world's most popular sleeping pill, was banned in Britain in 1991 on advice from the Government's drug safety advisers. New data was submitted on psychiatric side-effects and there was a storm of controversy - particularly in the United States - over claims about the drug's side- effects, including that it could make some patients violent with long-term use.



During the hearing, Upjohn claimed it was defamed by the BBC, which accused it of keeping silent about alleged side-effects.



Yesterday, in a 295-page written judgment, Mr Justice Sir Anthony May awarded Upjohn damages of pounds 60,000 against the BBC and Mr Mangold following claims made in a Panorama programme entitled 'The Halcion Nightmare'.



Sir Anthony awarded Upjohn damages of pounds 25,000 against Professor Oswald following statements he made in an article in the New York Times. Professor Oswald also had damages of pounds 75,000 awarded against him in a related libel claim brought by Dr Drucker.



But in a counter-claim against Upjohn, the drug company was ordered to pay Professor Oswald damages of pounds 50,000. A spokesman for Upjohn said that costs, yet to be finalised, would follow the judgments in each of the claims. Sir Anthony said the BBC and Professor Oswald were wrong to accuse Upjohn of deliberately misleading regulators about possible side-effects of Halcion during the Panorama programme. 'The seriousness of the libels against Upjohn is in my judgement obvious and great,' he said.



A spokeswoman for Panorama said last night an appeal was being considered. 'This is a major blow for investigative journalism.'



David Hooper, a partner with Biddle & Company, Professor Oswald's solicitors, said: 'The central issue here is that Professor Oswald has been awarded twice what Upjohn was awarded against him. Professor Oswald's reputation has been vindicated.'



He said that in the judgment Sir Anthony described Upjohn's behaviour in a press release the company issued after the New York Times article as malicious and with a reckless disregard for the truth.



Mr Hooper said the judgment reflected the fact that the New York Times sold only '99 copies daily in this country'. The amount of damages awarded against Professor Oswald was affected by the 'tiny' extent of the publication of his views within the UK, via the New York Times. Such republication as there was within the jurisdiction was balanced.



'Upjohn knew perfectly well that the case that he was making was one which had to be considered seriously,' Sir Anthony stated. It is understood that the Medical Defence Union will pay Professor Oswald's costs.



Ley Smith, Upjohn's president and chief operating officer, said: 'We are very pleased with the verdict. It's a vindication for the company and its employees . . ' He added that the damages would be divided equally between Save the Children and Help the Aged

Scientology: Don’t Let Tom Cruise and John Travolta’s Membership Fool You ..don't be duped by FIDDAMAN

Scientology: Don’t Let Tom Cruise and John Travolta’s Membership Fool You


Dr. Steven Frye

http://guardianlv.com/2012/07/scientology-dont-let-tom-cruise-and-john-travoltas-membership-fool-you/

Google “SCIENTOLOGY RELATED SUICIDES and MURDERS” and you will find many articles on the dangers of this anti-psychiatry, anti-medication cult.





Modern psychiatry has truly miraculous, remarkably safe, life-saving medications and therapies to assist patients with all kinds of mental disorders, especially depression and suicidal thinking. Yet Tom Cruise and John Travolta constantly shove their dangerous propaganda on us.



Scientology’s own very stressful and toxic training further aggravates this by the “number of individuals [who] go crazy when exposed to the Hubbard Tech even absent malicious intent on the part of the persons applying the Tech. For example, [Andre Tabayoyon] saw John Colletto get psychotic after he was exposed to the OT III level (Operating the tan level III) materials. He got a pistol. In my presence, he shot his wife in the head. She died instantly. Then John ran a short distance before turning the pistol on himself and committing suicide. Moreover, John Travolta’s auditor told me of two occasions … John Travolta went into deep depression after auditing and therefore suffered a psychotic break.”



“I personally observed a number of other Scientologists go crazy and commit suicide as a result of the auditing processes…The results of Scientology’s hatred of medicine and psychiatry has lead to numerous deaths. The second half of this list describes five of those deaths.”

(Ref:An extract from an affidavit by Andre Tabayoyon)



Even without the trauma of this “training,” depression is a very common disorder in which suicidal ideas often occur. How many others that could have been treated and very easily saved have died unnecessarily because of this dangerous cult?



Regarding John Travolta and Kelly Preston’s son, “Jett had been having seizures on an average of every four days, until he started taking Depakote… the drug initially worked, reducing the frequency to approximately once every three weeks…Jett took Depokate for ‘several years,’ but it eventually lost its effectiveness, according to Ossi and McDermott.” They say “it began to cause serious physical damage” including “damage to Jett’s liver. And Jett went back to having at least one seizure every four days. So Travolta and Preston, after consulting neurosurgeons, stopped administering the drug.” (Ref:TMZ, Huffington Post, Access Hollywood, Us, People: 02/02/09, Updated: 05/25/11)



Incredible!!! Neurologists are usually the specialists that treat seizure disorders, unless they are intractable in which case neurosurgery can be very effective. But seizures are brain disorders and we know how Scientologists reject treatment of brain disorders. When Jett allegedly died from a seizure, how come no one challenged them as to why he was not on seizure medications? How come there was no indication of any blood levels of seizure meds on his autopsy?



With proper treatment it’s very likely that Jett Travolta would still be alive. Jehovah’s Witnesses are not allowed to let their children die for their religious beliefs. Why are Scientology celebrities allowed to let their children die without treatment when other citizens are not?



Scientology is believed to have played a strong role in the Tom Cruise and Katie Holmes divorce. She moved to New York where Scientology does not have the support it has in LA and after only a couple of weeks the divorce was finalized. The Scientologists certainly did not want a public divorce settlement hearing so everyone could learn the truth.



After Katie had their daughter, did she really want her to be raised with the potentially appalling beliefs of the Scientologists? Obviously not, as she just rejoined the Catholic Church about a week after her divorce was finalized and registered Suri in a Catholic School.



So Scientology is a very dangerous cult that can have a devastating effect on our relationships, especially marriage and family, our health and even our lives.

Citizen beware!

GlaxoSmithKline pays $3bn for lupus drug partner ....GSK on the up FIDDAMAN ?

GlaxoSmithKline pays $3bn for lupus drug partner


US biotech Human Genome Sciences accepts $14.25 a share after resisting advances of Europe's largest drug firm for months


http://www.guardian.co.uk/business/2012/jul/16/glaxosmithkline-human-genome-sciences-benlysta?newsfeed=true



Share 1

Email Julia Kollewe

guardian.co.uk, Monday 16 July 2012 15.41 BST

GSK's chief executive, Sir Andrew Witty, right, says of the deal: 'We are pleased to have reached a mutually beneficial agreement with HGS on friendly terms.' Photograph: Martin Godwin for the Guardian

GlaxoSmithKline has gained full control of lupus drug Benlysta after snapping up Human Genome Sciences in a negotiated $3bn deal, following three months of hostile pursuit of its long-term US partner.



Europe's largest pharmaceutical manufacturer agreed to pay $14.25 (£9.13) a share in cash for the US biotech, which until recently had steadfastly resisted its advances. The boards of both companies have approved the deal.



GSK had initially offered to pay $13 a share, valuing HGS at $2.6bn. It went directly to the US firm's shareholders with a tender offer in May, after HGS adopted a poison pill to thwart the bid. The US biotech also approached other large drug-makers about a takeover.



The price is double the $7.17 the Human Genome share price traded at before GSK's bid was made public in April.



In a near 20-year partnership, GSK and HGS developed and sold Benlysta, the first lupus drug in half a century. An estimated 1.6 million people in the world have lupus.



The two companies also co-operate in the development of two other medicines for diabetes and heart disease. The Maryland-based biotech uses the human gene map to develop protein and antibody drugs.



GSK's chief executive, Sir Andrew Witty, said: "We are pleased to have reached a mutually beneficial agreement with HGS on friendly terms and believe the combination of GSK and HGS represents clear financial and strategic logic for both companies and our respective shareholders."



His counterpart Thomas Watkins said: "After a thorough analysis of strategic alternatives, HGS has determined that a combination with GSK is the best course of action for our company and the best way to maximise value for our stockholders."



Despite bumping its offer 10% and paying a 99% premium to the share price before its interest was made public, industry analysts said GSK had got a good deal – to the frustration of Human Genome investors hoping for a price in the high-teens a share.



"I'm disappointed with the deal because I think Benlysta is actually going to be a good drug," said Carol Werther, an analyst at Summer Street Research. "Glaxo wanted to get this on the cheap and they were able to do it in the absence of other bidders."



GSK said it expected to achieve cost savings of at least $200 m by 2015.



Navid Malik, an industry analyst at Cenkos Securities, said the deal was "nice to have" rather than a need to have for GSK, whose $112bn market value dwarves that of Human Genome.



Shares in GSK were up 0.66% at £14.55 at the close of trading in London.



The drug industry has seen a flurry of deals recently, driven by big pharmaceutical companies' hunt for new medicines as many of their blockbuster drugs lose patent protection. In a two-stage deal, AstraZeneca teamed up with its US partner Bristol-Myers Squibb last month to buy diabetes drug developer Amylin for $7bn



US biotech Human Genome Sciences accepts $14.25 a share after resisting advances of Europe's largest drug firm for months

GLAXO executive ...can't even spell involved ....fiddaman twaddle blog exposed

3 comments:


Evelyn Pringle9:24 PM

Excellent expose! I posted a link on Facebook.

Reply
Anonymous1:50 AM

As a former senior executive of GlaxoSmithKline, I am appalled at the despicable actions of Andrew Witty and all the other former Execs invlved in the Marketing and Sales of GSK products during the years in question. I'm proud to say I was a part of an internal support function that practiced zero tolerance as it related to the ethical procurement of goods and services. Andrew Witty is a shameful fraud and it is unfortunate that the GSK stockholders are such a weak group and don't revolt and demand his and Sir Christopher's resignation. I am totally disgusted and embarassed by what has happened.



ReplyBOB FIDDAMAN [Fiddy]4:14 AM

If you have any information on the "despicable actions of Andrew Witty and all the other former Execs invlved in the Marketing and Sales of GSK products during the years in question", please feel free to drop me a line. Use the email box in the sidebar of this blog



Reply

"Waterloo Sunset" Joe Stilgo - heard this a few days ago on radio 2 on the Jamie Cullum show

GSK Unphased by an increasingly Unhinged Fiddaman in $2.6 billion bid for biotech firm Human Genome Sciences

GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech firm for three months, sources familiar with the situation said on Sunday.


http://www.reuters.com/article/2012/07/15/us-humangenome-glaxosmithkline-idUSBRE86E08P20120715

Human Genome, which rejected a $13-a-share offer in April from GlaxoSmithKline, its long-time partner, has come under pressure from investors to try and strike a deal with the British drugmaker in the absence of any alternative bids.



The U.S. company - an early pioneer of gene-based drug discovery - has set itself a July 16 deadline for finding higher bids, but interest has been limited because GSK already has marketing rights to its drugs.



U.S. biotech company Celgene was at one stage considering whether to bid, according to a source, but negative analyst and investor reaction when news of those discussions broke deterred the U.S. group.



Without alternative bids, Human Genome shareholders have been pressing the company's management to engage with GSK before July 16 to avoid a share price collapse - and that argument has been a trigger for the weekend discussions.



A spokesman for GSK declined to comment, while officials at Human Genome were not immediately available.



Last year Human Genome and GSK won approval for Benlysta, the first new treatment for lupus in 50 years. But the drug's launch disappointed investors and Human Genome's shares fell from a high above $25 to a low of $6.51 in December. Glaxo made its offer a few months later, prompting Human Genome to launch an auction with the help of Credit Suisse and Goldman Sachs.



Human Genome and GSK share rights to Benlysta. They are also collaborating on two other experimental drugs in late-stage trials for heart disease and diabetes, where GSK owns a large majority of the economic interest.



Buying Human Genome would give GSK full rights to these partnered drugs, underscoring the appetite among big drugmakers for biotech products to drive future sales.



GSK would be also be able to strip out costs and the company's chief executive, Andrew Witty, told investors in May he expected to deliver "an extraordinary return" through the acquisition.



Human Genome investors have been hoping that GSK will sweeten its offer and the shares closed on Friday at $13.58 - above GSK's offer but well down on the level of more than $15 hit in April, soon after the unsolicited offer was made public.



There have been a spate of acquisitions of biotech companies this year as large pharmaceutical companies seek to rebuild their pipelines after a wave of patent expiries.



Most recently, Bristol-Myers Squibb agreed to buy diabetes specialist Amylin Pharmaceuticals by sharing the $7 billion cost of the deal with AstraZeneca.



(Additional reporting by Soyoung Kim in New York; Editing by Susan Fenton)

@GSK - Baum & Hedlund not so clean themselves, hardly Snow White....no wonder they love Bob FIDDAMAN

A finger in every pie


Once you spot a GO unindicted co-con, they turn up every where you look. Michael Baum, recently located as a partner at LA firm Baum, Hedlund, Aristei, Guilford & Downey, is up to his neck in the brewing scandal surrounding Digital Lightwave Inc..A major shareholder at the company's IPO, Baum may be implicated further when the barrage of class action lawsuits against DIGL hit the courts.

Also uncovered: BHAGD's recent "victory against the psych empire".



 http://home.earthlink.net/~snefru/GO/new.html

Know the Attorneys for Scientology ....expose the underbelly that feeds FIDDAMAN

http://exposingtheunderbelly.blogspot.co.uk/2009/04/michael-lin-baum-56y-b4-10-52-clinton.html


Includes BAUM HEDLUND -



George “Skip” William Murgatroyd III 61y attorney (PTS/SP '88, patron '06) (UT) (Tracey Forbes Murgatroyd 58y (Solo Nots I '97), ex-w: Joy L. Callahan, Jack William Murgatroyd (TR '05), f:George W. Murgatroyd II b:12-4-16 d:3-15-99


CCHR (lost against Eli Lilly pharma. Company)

Coale, Kananak & Murgatroyd

6956 Dume Drive

Malibu, CA 90265-4227 (310) 457-6035 skipmurgatroyd@hotmail.com



Michael Lin Baum 57 years old Clinton, OK, attorney (119511)(D.C.) unindicted co-conspirators (Operation SnowWhite, 'so scientology can have snow white hands' steals federal documents about Hubbard and scientology) (Melissa J. Sirkel Baum 43y)

Baum, Hedlund, Aristei, Schiavo law firm

Paul James Hedlund 63 years old (wife is Marta Louise (Brewer) Hedlund 52y teacher at Rosemont Middle School), ex-wife is Marie Olga (Kiraly) Hedlund 62

J. Clark Aristei

Gary Alan Brown 59 years old (litigant assistant, OSA, Integrity '87)

12100 Wilshire Blvd., Suite 950,

Los Angeles, CA 90025-7106 310-207-3233



more here - http://exposingtheunderbelly.blogspot.co.uk/2009/04/michael-lin-baum-56y-b4-10-52-clinton.html

FIDDAMAN (Goebbles) tries to control Twitter by insisting PARODY account viewing is blocked

FIDDAMAN FAILS yet again as Lilly Cymbalta pediatric studies lead to patent extension

Lilly extends grip on U.S. rights to Cymbalta




Fri Jul 6, 2012 3:09pm BST


http://uk.reuters.com/article/2012/07/06/us-lilly-cymbalta-idUKBRE8650KY20120706

(Reuters) - Eli Lilly & Co said on Friday that it gained six more months of U.S. exclusivity on its Cymbalta antidepressant for conducting pediatric studies, extending Lilly's hold on the $4 billion-a-year drug until December 2013.



Drugmakers are frequently awarded six months of additional patent life on their medicines for conducting studies in children, an incentive U.S. lawmakers created because of a perceived lack of pediatric studies of medicines.



However, Lilly said that, based on the study results, it would not seek approval to expand use of Cymbalta for children. Cymbalta is approved in the United States only for use in individuals 18 years and older, the company noted.



6 Stocks to Buy NowDownload Free ReportUse of antidepressants for children has a controversial history. The Food and Drug Administration in 2004 warned of an increased risk of suicidal thoughts or behavior in children and adolescents treated with some antidepressants.



About 11 percent of adolescents have a depressive disorder by age 18, according to a survey cited by the National Institute of Mental Health.



The extension of exclusivity on Cymbalta is a boost to Lilly as it grapples with the loss last October of its U.S. patent for Zyprexa, an antipsychotic that was its previous top-selling product.



Shares of Lilly were off 0.5 percent at $42.64 in morning trade on the New York Stock Exchange, a slightly better performance than for the weak overall U.S. markets.



(Reporting by Lewis Krauskopf; Editing by Gerald E. McCormick and Steve Orlofsky)

Antidepressants N Zealand 1921 - 2003 ...@MikePero check out the Bob FIDDAMAN blog ..CSAPER is Scientology

Citalopram - Mother of murder victim in legal bid over new inquest into killer's death - decision soon FIDDAMAN?

Mother of murder victim in legal bid over new inquest into killer's death


By WicklowNews.net, Jun 11th 2012, 16:51

RTE reports the mother of a 22-year-old man stabbed to death in Bray almost three years ago, has begun legal proceedings to have a new inquest held into his killer's death.



Nuala Creane, whose son Sebastian was stabbed to death by Shane Clancy at the Creane home in Bray, has been given permission by the High Court to challenge the Attorney General's refusal to direct a new inquest into Mr Clancy's death.



She is also challenging the failure of the Minister for Justice to make any decision on a complaint by her about the conduct of the Coroner for East Wicklow, Cathal Louth, who conducted the inquest into Mr Clancy's death.



Mr Clancy, 22, stabbed himself to death in the early hours of 16 August 2009 after stabbing his former girlfriend Jennifer Hannigan, her new boyfriend Sebastian Creane and Sebastian's brother, Dylan. Sebastian died from his injuries.



The inquest into Mr Creane's death returned a verdict of unlawful killing and found that he died of a knife wound to the heart.



The inquest into Mr Clancy's death returned an open verdict.



Mr Clancy's mother told the inquest she believed her son's actions were the result of the prescribed anti depressants he had been taking.



The inquest heard he had "toxic to fatal" levels of the anti-depressant Cipramil in his system and evidence was given that he may have suffered an adverse reaction to the drug.



Lawyers for Mrs Creane told the High Court that the inquest into Mr Clancy's death was the only public judicial or quasi judicial forum in which the circumstances of the killing of Mr Creane would ever be fully considered, investigated or explored.



Mrs Creane says in advance of the inquest into Mr Clancy's death, the coroner, reassured her and her husband about how he intended to conduct the inquest and to address expert evidence in respect of the purported relationship between the anti-depressant medication and the behaviour of Mr Clancy.






The Creanes claim the coroner failed to conduct the inquest in an open, fair or balanced manner and they say there was no reasonable or fair inquiry into the relevant circumstances surrounding the killing.






The High Court gave permission to Mrs Creane to proceed with her challenge and it will be before the court again next month

Citalopram - did antidepressant cause loss of control leading to murder? - see FIDDAMAN blog

David Leeman's antidepressants may have caused loss of control

Jennie Leeman was shot six days after her husband learned of her affair Continue reading the main story

http://www.bbc.co.uk/news/uk-england-devon-18771406



Related Stories

Killer heard 'voices' in his head

Wife shot 'to protect children'

Husband shot 'secret affair' wife

Antidepressants may have contributed to a killer's loss of control when he shot his wife, a court has heard.



David Leeman, of Higher Cowley Farm, Parracombe, Devon, shot wife Jennie, 44, five times at close range last September.



The 60-year-old denies murder but admits manslaughter on the grounds of loss of control.



A pharmacologist told the court Mr Leeman's symptoms were consistent with an adverse reaction to antidepressants.



Dr Andrew Herzheimer said Mr Leeman' feelings of being out of control and his sense of confusion were probably caused by his medication.



Behavioural changes



Mr Leeman had been taking a sedative anti-anxiety drug called Lorazepam for many years and had more recently also been prescribed the antidepressant Citalopram.



Citalopram, Dr Herzheimer said, was a drug closely linked to the controversial medication Seroxat, which has been blamed for sudden changes in behaviour in some users.



He said Mr Leeman's medical notes showed his dosage of Citalopram had been increased from 40 to 60 mg just six days before the killing, when he complained of anxiety over his marriage break up.



"He described feeling as if he was splitting in two and that is what is known as de-realisation and is consistent with a reaction to medication," the pharmacologist said.



Both the drugs Mr Leeman was taking would have caused confusion, he said, acting "a bit like alcohol" by decreasing inhibitions and increasing impulsiveness, recklessness and allowing more primitive and uncontrolled feelings to emerge.



Warnings ignored



But prosecution expert Professor Robin Ferner told the jury the increase in Mr Leeman's dosage was not enough to lead to "drastic and sudden" behavioural changes.



He said the medication was designed to reduce his anxiety and tension and should have calmed him down and made him able to cope with his wife's departure.



Mr and Mrs Leeman, who had four children, separated after Mr Leeman admitted a historic affair.



Mrs Leeman then began an affair with 40-year-old Norman Laramy, whom Mr Leeman wrongly thought was a paedophile.



Devon and Cornwall Police investigated Mr Laramy, but found no evidence of sexual offending.



Six days after learning of the affair, Mr Leeman killed his wife using an illegal semi-automatic pistol at almost point-blank range.



Mr Leeman claimed he lost control and shot his wife after she refused to listen to his warnings about her new lover.



The trial continues.

GSK GlaxoSmithKline fraud - nobody is going to jail. No executive was even charged. ...big deal FIDDAMAN !

After six years of bribing American doctors, pushing antidepressants on children and hiding the heart attack risk of a diabetes drug, the British drug Company GlaxoSmithKline LLC got a slap on the wrist this week.


http://www.huffingtonpost.com/larry-bodine/post_3573_b_1652688.html

•Glaxo agreed to pay $3 billion in fines for improperly pushing antidepressants Paxil and Wellbutrin, and diabetes drug Avandia, for many years. It is a pittance to Glaxo, which had $44 billion in sales in 2011 alone.

•The settlement is billed as "the largest health care fraud settlement in U.S. history." But Glaxo had already saved up to pay the fine. The settlement will barely affect the bottom line and the news of the settlement actually sent the stock price up.

•Glaxo pleaded guilty to health fraud but nobody is going to jail. No executive was even charged.




Kudos to the Department of Justice for nailing Glaxo. "At every level, we are determined to stop practices that jeopardize patients' health, harm taxpayers, and violate the public trust -- and this historic action is a clear warning to any company that chooses to break the law," said James M. Cole, Deputy Attorney General.



But to a massive operation like Glaxo, the fines amount to a speeding ticket. Admitting to meaningless criminal charges and paying penalties for poisoning consumers is just a cost of doing business.



What Glaxo Did to the Public



Paxil: For four years, Glaxo illegally promoted Paxil for treating depression in patients under age 18, even though the FDA has never approved this use. Glaxo helped in preparing, publishing and distributing a misleading medical journal article that misreported that a clinical trial of Paxil was effective in treating depression in patients under age 18, when the study failed to demonstrate efficacy. At the same time, the criminal pharma company hid data from two other studies in which Paxil also failed to help depression in minors.



Meanwhile, Glaxo sponsored dinner programs, lunch programs, spa programs and similar activities to promote the use of Paxil in children and adolescents. Glaxo paid a speaker to talk to an audience of doctors and paid for the meal or spa treatments for the doctors who attended. Glaxo agreed to plead guilty to misbranding Paxil in that its labeling was false and misleading regarding the use of Paxil for patients under 18.




Wellbutrin: For four years Glaxo promoted Wellbutrin, approved at that time only for Major Depressive Disorder, as a treatment for weight loss, sexual dysfunction, substance addictions and Attention Deficit Hyperactivity Disorder, among other off-label uses. The executives at Glaxo paid millions to doctors to speak at and attend meetings, sometimes at lavish resorts, where the off-label uses of Wellbutrin were routinely promoted and also used sales representatives, sham advisory boards, and phony Continuing Medical Education (CME) programs to promote Wellbutrin for these unapproved uses. Glaxo has agreed to plead guilty to misbranding Wellbutrin in that its labeling did not bear adequate directions for these off-label uses.



Avandia: For six years Glaxo lied to the FDA about the safety of Avandia, a diabetes drug, in reports to the FDA that are meant to allow the agency to determine if a drug is safe. The missing information about the risk of heart failure and heart attacks included data regarding post-marketing studies, as well as data regarding two studies undertaken in response to European regulators' concerns about the cardiovascular safety of Avandia. Glaxo has agreed to plead guilty to failing to report data to the FDA and has agreed to pay a criminal fine of $242,612,800 for its unlawful conduct concerning Avandia.



Another criminal pharma company, Abbot Labs, just agreed to pay a pay $1.5 billion in a settlement involving the anti-seizure drug Depakote in May 2012. Abbot was illegally bribing pharmacists to recommend it to defenseless elderly dementia patients for improper uses.



The previous U.S. record for the largest financial penalty paid by a pharmaceutical company for illegal marketing of drugs is the $2.3 billion mark set by Pfizer and its subsidiaries in 2009.



Looking Out for Yourself



If you have taken any drug manufactured by Glaxo -- including Paxil, Wellbutrin or Avandia -- search online and read articles to determine whether you have suffered any of the dangerous side effects. The $3B fines are being paid to the government -- not individual consumers. If you believe you have been damaged by a Glaxo drug, contact a lawyer who has experience dealing with pharmaceutical companies. Pharma companies have vast funds and battalions of lawyers to fight consumer claims, and you should be sure your lawyer has the resources to take on a criminal drug company.



And before you go, leave a comment below about this article and the fines being levied against drug companies. Should pharma companies be given penalties that affect their bottom line? Should individual executives in charge of paying bribes be personally indicted? Tell us what you think.



Cross-posted from Lawyers.com.



Content concerning legal matters is for informational purposes only, and should not be relied upon in making legal decisions or assessing your legal risks. Always consult a licensed attorney in the appropriate jurisdiction before taking any course of action that may affect your legal rights.

two weeks after Shane Clancy murder suicide - CCHR / Scientology were on the streets of Bray - FIDDAMAN

By Claire Murphy






Monday September 07 2009




A Church of Scientology-backed organisation has distributed free DVDs about anti-depressant drugs in the area where killer Shane Clancy lived.



The group, called the Citizens Commission on Human Rights (CCHR), has given out copies of a documentary to residents in the Dalkey area, just weeks after the tragic murder-suicide in Bray.



Reports have indicated that gardai are investigating whether Shane, who murdered Seb Creane (22) before killing himself, may have misused anti-depressants that had been prescribed for him a week before the tragic night.



The DVD, which is also available online, details interviews with psychiatrists, psychologists, and journalists, exposing what it calls "psychiatric violations of human rights."



Making A Killing: The Untold Story Of Psychotropic Drugging is made in the US, but has been distributed in Ireland by a branch of the CCHR.



The DVD's tagline says it tells the "story of big-money drugs that fuel a $330bn psychiatric industry, without a single cure."



But since its release, one professional involved with the DVD has distanced himself from the CCHR.



Professor Howard Brody said that he believes anything produced by this organisation requires independent confirmation.



He said: "I regret very much allowing myself to have become involved in this project and would like it to be known that I disown and disapprove of the final product and the way that it has been disseminated."



One expert witness at the Columbine shootings has contacted the Herald to say that Shane Clancy may have reacted negatively to anti-depressants, affecting his state of mind at the time of the attack.



The executive director of the International Coalition for Drug Awareness, Dr Ann Tracy, believes that Shane may have lacked vital liver function necessary to metabolise anti-depressants.



The US-based doctor pointed out that if levels of anti-depressant in Shane's blood were high, it does not necessarily mean that he was taking more than he should have.



She said: "It can mean that he, like seven to 10pc of the population, lacked the liver function necessary to break down the drug causing it to build to toxic levels."



CCHR spokesman Brian Daniels said the DVD was intended to "let the public know what is going on."



He said: "There are undiagnosed physical conditions which can manifest as mental illness."



clairemurphy@herald.ie

Cipramil citalopram murder ? - Shane Clancy "stalked" victim Seb Creane, mother claims - FIDDAMAN

Creanes angry at 'gruesome, futile' inquests



http://www.independent.ie/national-news/courts/creanes-angry-at-gruesome-futile-inquests-2168553.html

THE family of Sebastian Creane have accused his killer's family of being in denial about his motives.




In a statement read out after the inquest at Wicklow District Court yesterday into the death of their 22-year-old son, the Creanes described the inquest process as "gruesome and futile" and said they ought to have been allowed ask questions at last month's inquest into the death of Shane Clancy, who stabbed Mr Creane to death at the family home in Bray, Co Wicklow, on August 16 last year.



Clancy, who later killed himself, targeted Mr Creane because he was dating Jennifer Hannigan, whom Clancy had split from earlier last year.



"Everything that took place on August 16 was known before the day was out. Nonetheless we have had to worry about and endure the gruesome and futile ritual of two coroners' inquests, which have done nothing to advance knowledge of the facts," Mr Creane's parents, Nuala and James, and brother Dylan said in their statement.



They said they wanted to challenge the "assumption" that Shane stabbed Mr Creane, his brother and Ms Hannigan as a result of prescribed medication.



"Let us not forget what happened here. Seb was stalked by a person who, having manoeuvred his way into our home, left, armed himself and returned sometime later to complete his objective.



"By playing on Seb's better nature, he once again gained access to the house, killed Seb, attempted to kill Jen and then Dylan before withdrawing to kill himself.



"We cannot comprehend that an attempt was made to ascribe fault to prescribed medication without any corresponding attempt being made to consider all other factors.



"Healing for all parties will inevitably be difficult, but no true healing can ever be founded on denial."



Mr Creane was fatally attacked by Clancy, also 22, at his home in Cuala Grove, Bray.



Dylan Creane was repeatedly stabbed, as was Ms Hannigan. Clancy then turned the knife on himself.





Depressed



An inquest into Clancy's death last month heard how he had initiated a split from Ms Hannigan, from Dalkey, Dublin, in April and, despite remaining friends, he became depressed.



He wanted them to get back together but she did not. In July, he was prescribed anti-depressant Cipramil, and, according to his mother, became agitated, and tried to take his own life.



He was found with 3.1mg of Cipramil in his blood, which is 15 times the upper therapeutic dose and a level described as between toxic and lethal.



The jury rejected an option of death by suicide and returned an open verdict, adding that Clancy had died by self-inflicted injuries.



Clancy's mother, Leonie Fennell, last night said she didn't want to make a statement as there has been enough hurt caused already.



"There's nothing I can say except that they didn't know Shane," she told the Irish Independent. "And we wouldn't have gotten an open verdict (if we were wrong). They're (Creane family) very hurt and I don't want to cause any more hurt."



- Edel Kennedy



Irish Independent